Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Synthesis and biological evaluation of bicyclic nucleosides as inhibitors of M. tuberculosis thymidylate kinase.

Van Daele I, Munier-Lehmann H, Hendrickx PM, Marchal G, Chavarot P, Froeyen M, Qing L, Martins JC, Van Calenbergh S.

ChemMedChem. 2006 Oct;1(10):1081-90.

PMID:
16921580
2.

In vivo efficiency of targeted norfloxacin against persistent, isoniazid-insensitive, Mycobacterium bovis BCG present in the physiologically hypoxic mouse liver.

Balazuc AM, Lagranderie M, Chavarot P, Pescher P, Roseeuw E, Schacht E, Domurado D, Marchal G.

Microbes Infect. 2005 Jun;7(7-8):969-75.

PMID:
15994108
3.

Targeted norfloxacin is active in vivo against persistent Mycobacterium bovis BCG.

Domurado D, Balazuc AM, Lagranderie M, Pescher P, Chavarot P, Roseeuw E, Coessens V, Stern S, Schacht E, Marchal G.

J Control Release. 2005 Jan 3;101(1-3):343-5. No abstract available.

PMID:
15838943
4.

A nose-only apparatus for airborne delivery of Mycobacterium tuberculosis to mice: calibration of biological parameters.

Louveau C, Descroix D, Garnier L, Delamanche I, Chavarot P, Ramisse F, Marchal G, Vergnaud G.

Microbes Infect. 2005 Mar;7(3):457-66. Epub 2005 Mar 2.

PMID:
15792637
5.

Synthesis, degradation, and antimicrobial properties of targeted macromolecular prodrugs of norfloxacin.

Roseeuw E, Coessens V, Balazuc AM, Lagranderie M, Chavarot P, Pessina A, Neri MG, Schacht E, Marchal G, Domurado D.

Antimicrob Agents Chemother. 2003 Nov;47(11):3435-41.

6.

[Preliminary study on isoniazid-epiroprim combination in a tuberculosis murine model].

N'guessan K, Dosso M, Marchal G, Chavarot P, Romain F, Pescher P, Edy.

Bull Soc Pathol Exot. 2002 Nov;95(4):265-8. French.

PMID:
12596375
7.

Development of mixed Th1/Th2 type immune response and protection against Mycobacterium tuberculosis after rectal or subcutaneous immunization of newborn and adult mice with Mycobacterium bovis BCG.

Lagranderie M, Balazuc AM, Abolhassani M, Chavarot P, Nahori MA, Thouron F, Milon G, Marchal G.

Scand J Immunol. 2002 Mar;55(3):293-303.

8.

Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guérin infection in the absence of secreted TNF and lymphotoxin-alpha.

Olleros ML, Guler R, Corazza N, Vesin D, Eugster HP, Marchal G, Chavarot P, Mueller C, Garcia I.

J Immunol. 2002 Apr 1;168(7):3394-401.

9.

Mycobacterium bovis BCG induces similar immune responses and protection by rectal and parenteral immunization routes.

Abolhassani M, Lagranderie M, Chavarot P, Balazuc AM, Marchal G.

Infect Immun. 2000 Oct;68(10):5657-62.

10.

Immunogenicity and protective capacity of Mycobacterium bovis BCG after oral or intragastric administration in mice.

Lagranderie M, Chavarot P, Balazuc AM, Marchal G.

Vaccine. 2000 Jan 18;18(13):1186-95.

PMID:
10649619
11.

Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine.

Jackson M, Phalen SW, Lagranderie M, Ensergueix D, Chavarot P, Marchal G, McMurray DN, Gicquel B, Guilhot C.

Infect Immun. 1999 Jun;67(6):2867-73.

12.

Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene.

Berthet FX, Lagranderie M, Gounon P, Laurent-Winter C, Ensergueix D, Chavarot P, Thouron F, Maranghi E, Pelicic V, Portnoï D, Marchal G, Gicquel B.

Science. 1998 Oct 23;282(5389):759-62.

13.

Mycobacterium tuberculosis strains unidentified using the IS6110 probe can be detected by oligonucleotides derived from the Mt308 sequence.

Thierry D, Chavarot P, Marchal G, Le Thi KT, Ho ML, Nguyen NL, Le NV, Ledru S, Fumoux F, Guesdon JL.

Res Microbiol. 1995 May;146(4):325-8. No abstract available.

PMID:
7569326
14.

Identification of a Mycobacterium bovis BCG 45/47-kilodalton antigen complex, an immunodominant target for antibody response after immunization with living bacteria.

Romain F, Laqueyrerie A, Militzer P, Pescher P, Chavarot P, Lagranderie M, Auregan G, Gheorghiu M, Marchal G.

Infect Immun. 1993 Feb;61(2):742-50.

Supplemental Content

Loading ...
Support Center